<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>SULF 10- sulfacetamide sodium solution </strong><br>Novartis Ophthalmics<br></p></div>
<h1>Sulf 10</h1>
<div class="Contents">
<div class="Section">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-2"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">S</span><span class="Bold">u</span><span class="Bold">lf-</span><span class="Bold">1</span><span class="Bold">0</span><span class="Bold"><span class="Sup">®</span></span></p>
<p><span class="Bold">(SULFACETAMIDE SODIUM</span></p>
<p><span class="Bold">Ophthalmic Solution, USP) </span><span class="Bold">1</span><span class="Bold">0%</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-3"></a><p></p>
<h1><span class="Bold">DESCRIPTION</span></h1>
<p class="First">Sulfacetamide sodium ophthalmic solution, USP, is a sterile, topical anti-bacterial agent for ophthalmic use. The active ingredient is represented by the following structural formula:</p>
<p><img alt="Image from Drug Label Content" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=43AAB37C-3020-4F7E-8B21-F9BE22E9D356&amp;name=sulf10-figure-01.jpg"></p>
<p>Chemical name: <span class="Italics">N</span>-Sulfanilylacetamide monosodium salt monohydrate.</p>
<p><span class="Bold">THE PLASTIC SQUEEZE BOTTLE CONTAINS:</span></p>
<p><span class="Bold">Active:</span> Sulfacetamide Sodium 10% (100 mg/mL).</p>
<p><span class="Bold">Preservative: </span>Thimerosal 0.1 mg/mL</p>
<p><span class="Bold">Inactives: </span>Boric acid, hydroxypropyl methylcellulose 2208 (4000 cps) 1.0 mg/mL, sodium thiosulfate and purified water. Sodium carbonate anhydrous and/or hydrochloric acid to adjust pH (7.0-7.4) when necessary.</p>
<p><span class="Bold">THE DROPPERETTES</span><span class="Bold"><span class="Sup">®</span></span><span class="Bold"> APPLICATOR CONTAINS:</span></p>
<p><span class="Bold">Active:</span> Sulfacetamide Sodium 10% (100 mg/mL).</p>
<p><span class="Bold">Preservative: </span>Thimerosal 0.05 mg/mL</p>
<p><span class="Bold">Inactives: </span>Boric acid, sodium thiosulfate and purified water. Sodium carbonate anhydrous and/or hydrochloric acid to adjust pH (7.0-7.4) when necessary.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-4"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY</span></h1>
<p class="First"><span class="Bold">Microbiology</span></p>
<p>The sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all. Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase. Resistant <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> have altered dihydropteroate synthetase with reduced affinity for sulfonamides or produce increased quantities of aminobenzoic acid.</p>
<p>Topically applied sulfonamides are considered active against susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following common bacterial eye pathogens: <span class="Italics">Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus</span> (viridans group), <span class="Italics">Haemophilus influenzae, Klebsiella </span>species<span class="Italics">,</span> and <span class="Italics">Enterobacter </span>species.</p>
<p>Topically applied sulfonamides do not provide adequate coverage against <span class="Italics">Neisseria </span>species, <span class="Italics">Serratia marcescens </span>and <span class="Italics">Pseudomonas aeruginosa. </span>A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-5"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE</span></h1>
<p class="First">For the treatment of <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> and other superficial ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to susceptible microorganisms and as an adjunctive in systemic sulfonamide therapy of trachoma:</p>
<p><span class="Italics">Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus</span> (viridans group), <span class="Italics">Haemophilus influenzae, Klebsiella </span>species<span class="Italics">,</span> and <span class="Italics">Enterobacter </span>species.</p>
<p>Topically applied sulfonamides do not provide adequate coverage against <span class="Italics">Neisseria </span>species, <span class="Italics">Serratia marcescens </span>and <span class="Italics">Pseudomonas aeruginosa.</span> A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-6"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS</span></h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to sulfonamides or to any ingredient of the preparation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-7"></a><p></p>
<h1><span class="Bold">WARNINGS</span></h1>
<p class="First">FOR TOPICAL EYE USE ONLY – NOT FOR INJECTION. FATALITIES HAVE OCCURRED, ALTHOUGH RARELY, DUE TO SEVERE REACTIONS TO SULFONAMIDES INCLUDING <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">STEVENS-JOHNSON SYNDROME</span>, <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">TOXIC EPIDERMAL NECROLYSIS</span>, FULMINANT <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">HEPATIC NECROSIS</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">AGRANULOCYTOSIS</span>, <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">APLASTIC ANEMIA</span> AND OTHER <span class="product-label-link" type="condition" conceptid="40528016" conceptname="Disorder of hematopoietic system">BLOOD DYSCRASIAS</span>. Sensitizations may recur when a sulfonamide is readministered, irrespective of the route of administration. Sensitivity reactions have been reported in individuals with no prior history of sulfonamide <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>. At the first sign of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span> or other serious reaction, discontinue use of this preparation.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-8"></a><p></p>
<h1><span class="Bold">PRECAUTIONS</span></h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-8.1"></a><p></p>
<h2><span class="Bold">General</span></h2>
<p class="First">Prolonged use of topical anti-bacterial agents may give rise to overgrowth of nonsusceptible organisms including fungi. <span class="product-label-link" type="condition" conceptid="4207042" conceptname="Viral resistance">Bacterial resistance</span> to sulfonamides may also develop.</p>
<p>The effectiveness of sulfonamides may be reduced by the para-aminobenzoic acid present in purulent exudates.</p>
<p>Sensitization may recur when a sulfonamide is readministered irrespective of the route of administration, and cross-sensitivity between different sulfonamides may occur.</p>
<p>At the first sign of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, increase in <span class="product-label-link" type="condition" conceptid="4145093" conceptname="Purulent discharge">purulent discharge</span>, or aggravation of <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span> or <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, the patient should discontinue use of the medication and consult a physician (see WARNINGS).</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-8.2"></a><p></p>
<h2><span class="Bold">Information for patients</span></h2>
<p class="First">To avoid contamination, do not touch tip of container to eye, eyelid or any surface.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-8.3"></a><p></p>
<h2><span class="Bold">Drug Interactions</span></h2>
<p class="First">Sulfacetamide preparations are incompatible with silver preparations.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-8.4"></a><p></p>
<h2><span class="Bold">Carcinogenesis, Mutagenesis, Impairment of Fertility</span></h2>
<p class="First">No studies have been conducted in animals or in humans to evaluate the possibility of these effects with ocularly administered sulfacetamide. Rats appear to be especially susceptible to the goitrogenic effects of sulfonamides, and long-term oral administration of sulfonamides has resulted in thyroid malignancies in these animals.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8.5"></a><p></p>
<h2><span class="Bold">Pregnancy</span></h2>
<div class="Section" data-sectionCode="42229-5">
<a name="section-8.5.1"></a><p></p>
<h3><span class="Bold Italics">Pregnancy Category C.</span></h3>
<p class="First">Animal reproduction studies have not been conducted with sulfonamide ophthalmic preparations. <span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">Kernicterus</span> may occur in the newborn as a result of treatment of a pregnant woman at term with orally administered sulfonamides. There are no adequate and well controlled studies of sulfonamide ophthalmic preparations in pregnant women and it is not known whether topically applied sulfonamides can cause fetal harm when administered to a pregnant woman. This product should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-8.6"></a><p></p>
<h2><span class="Bold">Nursing Mothers</span></h2>
<p class="First">Systemically administered sulfonamides are capable of producing <span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">kernicterus</span> in infants of lactating women. Because of the potential for the development of <span class="product-label-link" type="condition" conceptid="4326231" conceptname="Kernicterus">kernicterus</span> in neonates, a decision should be made whether to discontinue nursing or discontinue the drug taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-8.7"></a><p></p>
<h2><span class="Bold">Pediatric Use</span></h2>
<p class="First">Safety and effectiveness in pediatric patients below the age of two months have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-9"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS</span></h1>
<p class="First">Bacterial and fungal <span class="product-label-link" type="condition" conceptid="373202" conceptname="Corneal ulcer">corneal ulcers</span> have developed during treatment with sulfonamide ophthalmic preparations.</p>
<p>The most frequently reported reactions are local irritation, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> and burning. Less commonly reported reactions include non-specific <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival hyperemia</span>, <span class="product-label-link" type="condition" conceptid="442777" conceptname="Generalized infection during labor">secondary infections</span> and <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>.</p>
<p>Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span>, <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">toxic epidermal necrolysis</span>, fulminant <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">hepatic necrosis</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span>, and other <span class="product-label-link" type="condition" conceptid="40528016" conceptname="Disorder of hematopoietic system">blood dyscrasias</span> (see WARNINGS).</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION:</span></h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-10.1"></a><p></p>
<h2><span class="Bold">For <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> and other superficial ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>:</span></h2>
<p class="First">Instill one or two drops into the conjunctival sac(s) of the affected eye(s) every two to three hours initially. Dosages may be tapered by increasing the time interval between doses as the condition responds. The usual duration of treatment is seven to ten days.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-10.2"></a><p></p>
<h2><span class="Bold">For Trachoma:</span></h2>
<p class="First">Instill two drops into the conjunctival sac(s) of the affected eye(s) every two hours. Topical administration must be accompanied by systemic administration.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED</span></h1>
<p class="First">SULF-10 (sulfacetamide sodium ophthalmic solution, USP) 10% comes in:</p>
<p>15 mL plastic dropper-tip squeeze bottle.</p>
<p>NDC 58768-732-15.</p>
<p>Boxes of 12 x 1 mL Sterile-Pack DROPPERETTES<span class="Sup">®</span> Applicators.</p>
<p>NDC 58768-732-12.</p>
<p>To be dispensed in original unopened container.</p>
<p><span class="Bold">KEEP BOTTLE TIGHTLY CLOSED.</span></p>
<p><span class="Bold">STORE AT CONTROLLED ROOM TEMPERATURE</span><br>15°-30°C (59°-86°F).</p>
<p>Sulfonamide solutions darken on prolonged standing and exposure to heat and light. Do not use if solution has darkened. Yellowishness does not affect activity.</p>
<p><span class="Bold">KEEP OUT OF REACH OF CHILDREN.</span></p>
<p><span class="Bold">Rx only</span></p>
<p>Mfd. by OMJ Pharmaceuticals, Inc., San Germán, P.R., 00683<br>for: Novartis Ophthalmics, Duluth, GA 30097</p>
<p>I 6074-B</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>SULF 10 		
					</strong><br><span class="contentTableReg">sulfacetamide sodium solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:58768-732</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Sulfacetamide sodium</strong> (Sulfacetamide) </td>
<td class="formItem"></td>
<td class="formItem">100 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>boric acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>hydrochloric acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>hydroxypropyl methylcellulose 2208</strong></td>
<td class="formItem">1.0 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium carbonate anhydrous</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>sodium thiosulfate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>thimerosal</strong></td>
<td class="formItem">0.1 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:58768-732-15</td>
<td class="formItem">15 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>SULF 10 		
					</strong><br><span class="contentTableReg">sulfacetamide sodium solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:58768-732</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Sulfacetamide sodium</strong> (Sulfacetamide) </td>
<td class="formItem"></td>
<td class="formItem">100 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>boric acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>hydrochloric acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>sodium carbonate anhydrous</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium thiosulfate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>thimerosal</strong></td>
<td class="formItem">0.05 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:58768-732-12</td>
<td class="formItem">12  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1 mL in 1 APPLICATOR</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Novartis Ophthalmics</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 8/2006<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>43AAB37C-3020-4F7E-8B21-F9BE22E9D356</div>
<div>Set id: 43AAB37C-3020-4F7E-8B21-F9BE22E9D356</div>
<div>Version: 1</div>
<div>Effective Time: 20060810</div>
</div>
</div> <div class="DistributorName">Novartis Ophthalmics</div></p>
</body></html>
